Crossmark

EFICÁCIA DURADOURA DE DOLUTEGRAVIR (DTG) E LAMIVUDINA (3 TC) PARA TERAPIA ANTIRETROVIRAL DE ADULTOS COM INFECÇÃO POR HIV‐1 SEM TRATAMENTO PRÉVIO ‐ RESULTADO DE 3 ANOS DOS ESTUDOS GEMINI

Crossref DOI link: https://doi.org/10.1016/j.bjid.2020.101259

Published Print: 2021-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cahn, Pedro

Madero, Juan Sierra

Arribas, José Ramón

Sievers, Jörg

Man, Choy

Urbaityte, Rimgaile

Underwood, Mark

Wyk, Jean Andre Van

Smith, Kimberly

Zajdenverg, Roberto
License Information

Text and Data Mining valid from 2021-01-01

Version of Record valid from 2021-01-05
More Information

This article is maintained by: Elsevier

Article Title: EFICÁCIA DURADOURA DE DOLUTEGRAVIR (DTG) E LAMIVUDINA (3TC) PARA TERAPIA ANTIRETROVIRAL DE ADULTOS COM INFECÇÃO POR HIV‐1 SEM TRATAMENTO PRÉVIO ‐ RESULTADO DE 3 ANOS DOS ESTUDOS GEMINI

Journal Title: The Brazilian Journal of Infectious Diseases

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.bjid.2020.101259

Content Type: simple-article

Copyright: Copyright © 2020 Published by Elsevier Editora Ltda.

Document is current

Any future updates will be listed below